 Severity of Illness Index
"Severity of Illness Index" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Levels within a diagnostic group which are established by various measurement criteria applied to the seriousness of a patient's disorder.
| Descriptor ID |
D012720
|
| MeSH Number(s) |
E05.318.308.250.475.456.500 N05.715.360.300.375.375.364.500 N06.850.520.308.250.475.364.500
|
| Concept/Terms |
Severity of Illness Index- Severity of Illness Index
- Illness Index Severities
- Illness Index Severity
- Index Severities, Illness
- Index Severity, Illness
|
Below are MeSH descriptors whose meaning is more general than "Severity of Illness Index".
Below are MeSH descriptors whose meaning is more specific than "Severity of Illness Index".
This graph shows the total number of publications written about "Severity of Illness Index" by people in this website by year, and whether "Severity of Illness Index" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1987 | 0 | 1 | 1 | | 1988 | 1 | 0 | 1 | | 1990 | 1 | 1 | 2 | | 1991 | 2 | 0 | 2 | | 1992 | 1 | 2 | 3 | | 1993 | 0 | 2 | 2 | | 1994 | 2 | 3 | 5 | | 1995 | 4 | 3 | 7 | | 1996 | 8 | 6 | 14 | | 1997 | 0 | 10 | 10 | | 1998 | 2 | 6 | 8 | | 1999 | 2 | 15 | 17 | | 2000 | 0 | 14 | 14 | | 2001 | 1 | 13 | 14 | | 2002 | 1 | 21 | 22 | | 2003 | 1 | 28 | 29 | | 2004 | 0 | 18 | 18 | | 2005 | 2 | 29 | 31 | | 2006 | 1 | 40 | 41 | | 2007 | 1 | 38 | 39 | | 2008 | 2 | 45 | 47 | | 2009 | 5 | 31 | 36 | | 2010 | 5 | 36 | 41 | | 2011 | 6 | 35 | 41 | | 2012 | 7 | 32 | 39 | | 2013 | 4 | 48 | 52 | | 2014 | 2 | 30 | 32 | | 2015 | 8 | 51 | 59 | | 2016 | 1 | 15 | 16 | | 2017 | 2 | 12 | 14 | | 2018 | 0 | 4 | 4 |
To return to the timeline, click here.
Below are the most recent publications written about "Severity of Illness Index" by people in Profiles.
-
Martins TAF, Barbosa VS, Almeida GG, Antonelli LRDV, Tafuri WL, Mosser DM, Gonçalves R. Monocyte subpopulations as important biomarkers of resistence and susceptibility during experimental infection with Leishmania (Leishmania) major. Biomed Pharmacother. 2018 Nov; 107:1530-1539.
-
Gilbert ON, Choi CH, Franzil JL, Caughey M, Qureshi W, Stacey RB, Pu M, Applegate RJ, Gandhi SK, Zhao DXM. Comparison of paravalvular aortic leak characteristics in the Medtronic CoreValve versus Edwards Sapien Valve: Paravalvular aortic leak characteristics. Catheter Cardiovasc Interv. 2018 11 01; 92(5):972-980.
-
Praz F, Khalique OK, Lee R, Veeragandham R, Russell H, Guerrero M, Islam AM, Deaton DW, Kaneko T, Kodali SK, Leon MB, Bapat V, Takayama H, Borger MA, George I. Transatrial implantation of a transcatheter heart valve for severe mitral annular calcification. J Thorac Cardiovasc Surg. 2018 07; 156(1):132-142.
-
Kalesan B, Cheng TW, Farber A, Zuo Y, Kalish JA, Jones DW, Siracuse JJ. Readmissions after thoracic endovascular aortic repair. J Vasc Surg. 2018 08; 68(2):372-382.e3.
-
Choi YS, Jung MK, Lee J, Choi SJ, Choi SH, Lee HW, Lee JJ, Kim HJ, Ahn SH, Lee DH, Kim W, Park SH, Huh JR, Kim HP, Park JY, Shin EC. Tumor Necrosis Factor-producing T-regulatory Cells Are Associated With Severe Liver Injury in Patients With Acute Hepatitis A. Gastroenterology. 2018 03; 154(4):1047-1060.
-
King KR, Aguirre AD, Ye YX, Sun Y, Roh JD, Ng RP, Kohler RH, Arlauckas SP, Iwamoto Y, Savol A, Sadreyev RI, Kelly M, Fitzgibbons TP, Fitzgerald KA, Mitchison T, Libby P, Nahrendorf M, Weissleder R. IRF3 and type I interferons fuel a fatal response to myocardial infarction. Nat Med. 2017 Dec; 23(12):1481-1487.
-
Bronckers IMGJ, Seyger MMB, West DP, Lara-Corrales I, Tollefson M, Tom WL, Hogeling M, Belazarian L, Zachariae C, Mahé E, Siegfried E, Philipp S, Szalai Z, Vleugels RA, Holland K, Murphy R, Baselga E, Cordoro K, Lambert J, Alexopoulos A, Mrowietz U, Kievit W, Paller AS. Safety of Systemic Agents for the Treatment of Pediatric Psoriasis. JAMA Dermatol. 2017 Nov 01; 153(11):1147-1157.
-
Kapoor A, Matheos T, Walz M, McDonough C, Maheswaran A, Ruppell E, Mohamud D, Shaffer N, Zhou Y, Kaur S, Heard S, Crawford S, Cabral H, White DK, Santry H, Jette A, Fielding R, Silliman RA, Gurwitz J. Self-Reported Function More Informative than Frailty Phenotype in Predicting Adverse Postoperative Course in Older Adults. J Am Geriatr Soc. 2017 Nov; 65(11):2522-2528.
-
Trivedi M, ElMallah M, Bailey E, Kremer T, Rhein LM. Pediatric Obstructive Sleep Apnea and Asthma: Clinical Implications. Pediatr Ann. 2017 09 01; 46(9):e332-e335.
-
Liu LY, Strassner JP, Refat MA, Harris JE, King BA. Repigmentation in vitiligo using the Janus kinase inhibitor tofacitinib may require concomitant light exposure. J Am Acad Dermatol. 2017 Oct; 77(4):675-682.e1.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|